Australia firm freezes its first patient Can cryogenics help bring people back to life? firstpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from firstpost.com Daily Mail and Mail on Sunday newspapers.
(0)
Creating new sourcing, EryPharm envisions delivering red blood cells for transfusion.
EryPharm, startup created in 2016, has achieved a revolutionary technological breakthrough to mass-produce cultured red blood cells to develop new sourcing for blood transfusion. Supporting and complementing regular blood donation, this medical product will improve the quality of life of multi-transfused patients who suffer from hereditary or acquired diseases of the red blood cells in particular.
Blood transfusion is an essential medical practice that is frequently under the threat of limited availability. Each year, 120 million blood donations are realized in the world, of which 50% are accessible to only 16% of the world population. Even in developed countries, shortages are not uncommon (ex. aging population or epidemics limit blood collection). Furthermore, a diversity of donors induces the risk of transmitting diseases, even if the supply chain is carefully controlled.